The Salexa Sequencing by Synthesis

Alumina was founded by John Stupenagel, who went on to become one of the world's top genetic counselors. The company is now a leading provider of next generation sequencing technology for cancer and other diseases. Alumina has been in business since 2000; it recently raised its valuation from $200 million to more than $1 billion.